№ lp_1_2_10644
File format: docx
Character count: 21917
File size: 46 KB
This document provides an overview of the Plan Benefit Package (PBP) and formulary submission process for Medicare Advantage and Prescription Drug Plan organizations, detailing the regulatory background and ongoing updates to the software used in these submissions.
Year:
2018
Region / city:
United States
Subject:
Medicare Advantage, Prescription Drug Plan, Medicare
Document Type:
Supporting Statement
Organization / institution:
Centers for Medicare & Medicaid Services (CMS)
Author:
Centers for Medicare & Medicaid Services (CMS)
Target Audience:
Medicare Advantage (MA) and Prescription Drug Plan (PDP) organizations
Period of validity:
CY 2018 through CY 2019
Approval Date:
Not specified
Date of amendments:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2022
Region / City:
United States
Theme:
Medicare Advantage, Prescription Drug Plan, Health Policy
Document Type:
Report
Institution / Organization:
Centers for Medicare & Medicaid Services (CMS)
Author:
Centers for Medicare & Medicaid Services (CMS)
Target Audience:
Medicare Advantage and Prescription Drug Plan organizations, healthcare administrators, policy makers
Period of Validity:
CY 2022
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2023
Region / City:
Humber and North Yorkshire
Theme:
Medicine prescribing, healthcare guidelines
Document Type:
Guideline, formulary
Organization / Institution:
Humber and North Yorkshire Area Prescribing Committee
Author:
Humber and North Yorkshire Area Prescribing Committee
Target Audience:
Healthcare professionals (pharmacists, doctors, primary and secondary care providers)
Period of Validity:
Ongoing
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2023
Region / City:
North East and North Cumbria (NENC)
Topic:
Pharmaceutical product application
Document Type:
Form
Institution / Organization:
NHS
Author:
North East and North Cumbria ICB
Target Audience:
Clinicians, healthcare professionals, NHS staff
Period of Validity:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2020
Region / City:
Leicestershire, UK
Topic:
Wound Care, Compression Therapy
Document Type:
Formulary
Organization / Institution:
Leicestershire Partnership NHS Trust
Author:
Expert clinical group in consultation with staff
Target Audience:
Healthcare practitioners
Effective Period:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Content Description:
This formulary provides a list of wound care and compression therapy products available for use across the Leicestershire Partnership NHS Trust and associated Clinical Commissioning Groups, including specific usage guidelines and product recommendations.
Note:
Year
Subject:
Medicine Formularies, Health Policy
Document Type:
Form, Application
Institution:
Ministry of Health
Author:
Applicant (Consultant, Specialist, Medical Officer, Pharmacist)
Target Audience:
Healthcare Professionals, Drug and Therapeutic Committee
Context:
Form used to propose the inclusion of a medicine or indication from the Ministry of Health Medicines Formulary into an institution’s Medicines Formulary for approval by the institution’s Drug and Therapeutic Committee.
Year:
Not specified
Region / City:
Malaysia
Topic:
Pharmaceutical registration and formulary listing
Document Type:
Application Form
Organization / Institution:
Ministry of Health Malaysia
Author:
Not specified
Target Audience:
Pharmaceutical companies, regulatory authorities
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Amendments:
Not specified
Year:
2022
Region / City:
United States
Theme:
Medicare Advantage, Prescription Drug Plan, Health Policy
Document Type:
Report
Institution / Organization:
Centers for Medicare & Medicaid Services (CMS)
Author:
Centers for Medicare & Medicaid Services (CMS)
Target Audience:
Medicare Advantage and Prescription Drug Plan organizations, healthcare administrators, policy makers
Period of Validity:
CY 2022
Approval Date:
Not specified
Modification Date:
Not specified
Document type:
Prior authorization request letter
Medical specialty:
Gastroenterology
Condition:
Ulcerative colitis
Medication:
STELARA® (ustekinumab)
Request type:
Standard or expedited authorization
Intended recipient:
Medical Director of payer organization
Healthcare setting:
Hospital outpatient, outpatient clinic, private practice, or other
Purpose:
Formulary exception and coverage authorization
Supporting materials referenced:
Prescribing information, clinical guidelines, peer-reviewed literature
Source type:
Clinical administrative correspondence
Year:
2024
Region / City:
Bedfordshire, Luton, Milton Keynes
Topic:
Formulary Subgroup Meeting
Document Type:
Meeting Notes
Organization / Institution:
Bedfordshire, Luton and Milton Keynes Integrated Care Board (BLMK ICB)
Author:
Not specified
Target Audience:
Healthcare professionals, pharmacy representatives, medical professionals
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2025
Region / City:
N/A
Theme:
Pharmaceuticals
Document Type:
List
Organization / Institution:
N/A
Author:
N/A
Target Audience:
N/A
Period of Validity:
2025
Approval Date:
N/A
Date of Amendments:
N/A
Year:
Not specified
Region / City:
Not specified
Topic:
Medicine Prescriber Category Change
Document Type:
Form
Institution:
Ministry of Health (MOH)
Author:
Not specified
Target Audience:
Healthcare professionals involved in prescribing medicines
Effective Period:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Contextual Description:
Form for proposing changes to the prescriber category of medicines in the Ministry of Health Medicines Formulary, including necessary information about the medicine, dosage, and rationale for the change.
Year:
2023
Region / city:
Wales
Topic:
Healthcare, Pharmaceutical Services, Urinary Tract Infections
Document Type:
Consultation Document
Organization / Institution:
AWTTC (All Wales Therapeutic and Toxicology Centre)
Author:
Alwyn Fortune
Target Audience:
Healthcare professionals, pharmacists, public health authorities
Effective Period:
Until consultation closing date
Approval Date:
Not provided
Amendment Date:
Not provided
Year:
2020
Region / city:
Kent and Medway
Topic:
Healthcare, Pharmaceuticals
Document Type:
Application Form
Institution:
Kent and Medway Formulary Working Group
Author:
Kent and Medway MOT and Acute Trust Members, Joint Formulary Group Members, IMO - FWG
Target Audience:
Healthcare Professionals, Clinical Directors
Period of validity:
Not specified
Approval date:
Not specified
Date of amendments:
June 2023
Note:
Date
Year:
2023
Region / City:
Petaling Jaya, Selangor
Topic:
Medicines Formulary Submission
Document Type:
Letter
Organization:
Ministry of Health Malaysia
Author:
Not specified
Target Audience:
Pharmaceutical companies, regulatory bodies
Period of validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Contextual description:
A formal letter intended for submission of a dossier for the listing of a medicine in the Ministry of Health Malaysia’s Medicines Formulary, outlining the criteria for listing and resubmission.
Year:
2017
Region / City:
Buckinghamshire
Topic:
Healthcare regulation
Document Type:
Policy
Organization / Institution:
Buckinghamshire Healthcare NHS Trust
Author:
Maire Stapleton and Sarah Crotty
Target Audience:
FMG Committee Members, Healthcare Professionals
Effective Date:
February 2017
Review Date:
February 2030
Approvals:
Formulary Management Group
Linked to:
Annexe 4 Bucks Formulary policy
Departments Responsible for Updating:
BHT Formulary team, Aylesbury Vale and Chiltern CCGs Medicines Management Team
Record of Amendments:
v.1.1 September 2015, v.1.2 February 2017
Year:
2025
Region / city:
Bonn, Germany
Topic:
Ecological connectivity, CMS Article III.4
Document type:
Workshop preparatory material
Organization:
UNEP, CMS
Target audience:
Workshop participants, national legislators, conservation experts
Period of validity:
3–5 June 2025
Date of approval:
20 May 2025
Date of amendments:
N/A
Year:
July 2022
Note:
Region / City
Document Type:
Validation Checklist
Contextual description:
A validation checklist for medicinal product applications within the Decentralized Procedure (DCP) process.
Year:
Not specified
Region / City:
Not specified
Topic:
Business Continuity, Risk Management
Document Type:
Procedure
Organization / Institution:
Centers for Medicare & Medicaid Services (CMS)
Author:
Not specified
Target Audience:
Business Owners, CMS Stakeholders
Effective Period:
Every two years
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2019
Region / City:
Baltimore, Maryland
Topic:
Information Security, Network Interconnection
Document Type:
Agreement
Organization:
Centers for Medicare & Medicaid Services (CMS)
Author:
Centers for Medicare & Medicaid Services (CMS)
Target Audience:
Non-CMS Organizations, CMS IT and Security Personnel
Period of Action:
Ongoing
Approval Date:
August 9, 2019
Amendment Date:
Not specified